Dormotech Medical
Revolutionizing sleep health with an all-in-one, AI-driven diagnostics platform
Company Overview
Snapshot
Founded in January 2021 by Abed Nassir, Shimon Hayun, and Aharon Shapira, Dormotech Medical operates with 11–50 employees. The company has secured funding across three rounds from three investors, with G.O Innovation leading one of its seed rounds. In January 2024, Dormotech Medical received FDA approval for its wireless Type 2 Home Sleep Test (HST) device, which streams data in real-time.
Business overview
Dormotech Medical is a Digital Health company focused on monitoring and diagnosing sleep disorders. The company's core product, DormoVision X, is an AI-driven diagnostics platform equipped with patented technology and FDA clearance. It provides real-time physiological data monitoring and sleep analysis, aiming to match the accuracy of in-lab studies with the convenience of at-home testing. The platform includes a patient-centric device, user-friendly scoring, and reporting systems, leveraging machine-assisted scoring. Dormotech Medical serves the healthcare industry, including clinics, insurance companies, and healthcare providers, operating within the digital healthcare and medical devices sectors in the United States and Israel.
Strategic signal
In January 2024, Dormotech Medical announced FDA approval for its wireless Type 2 Home Sleep Test (HST) device, which streams data in real-time. This regulatory clearance is a significant validation of the company's technology, enabling broader market access and adoption within the US healthcare system. For investors, this signals a critical de-risking event and a strong indicator of the company's readiness for commercial scaling in a highly regulated market, positioning it as a competitive player in at-home sleep diagnostics.
Log in to access full profile ›Company Intelligence Q&A
- What is Dormotech Medical's primary focus?
- Dormotech Medical is a Digital Health company specializing in the monitoring and diagnosis of sleep disorders, offering an AI-driven diagnostics platform for at-home testing.
- When was Dormotech Medical founded and by whom?
- Dormotech Medical was founded in January 2021 by Abed Nassir, Shimon Hayun, and Aharon Shapira.
- What is DormoVision X?
- DormoVision X is Dormotech Medical's groundbreaking platform equipped with patented technology and FDA clearance, designed for comprehensive sleep testing with a patient-centric device and machine-assisted scoring.
- Has Dormotech Medical received any regulatory approvals?
- Yes, in January 2024, Dormotech Medical received FDA approval for its wireless Type 2 Home Sleep Test (HST) device, which streams data in real-time.